According to the new statement, the BioNTech and Pfizer Covid-19 vaccine approved by the European Medicines Agency on Monday, to be used across European Union.
The following development happened weeks after the shot was first authorized in Britain and United States.
After the closed-doors expert meeting, the shot was recommended by EU drug regulator to be given to people over 16 years of age.
However, the pharmaceutical companies will need to submit follow-up data on their vaccine for the next year.
Emer Cooke the head of the agency said, this is really a historic scientific achievement, as it is a significant step forward in our fight against the coronavirus pandemic.
Now, the Pfizer-BioNTech Covid-19 vaccine authorized by the European Medicines Agency chief
The approval needs to be rubber-stamped by the EU’s executive branch, a move its chief said is likely to happen Monday evening.
European Commission President Ursula von der Leyen tweeted that the EMA’s approval was “a decisive moment in our efforts to deliver safe & effective vaccines to Europeans!”
“A vaccine’s benefits in protecting people against COVID-19 must be far greater than any side effect or potential risks,” it said.